CytoSorbents Corp (CTSO)

Industry Medical Devices

This stock can be held in an Investment ISA and an Investment Account

Sell

$0.65

Buy

$0.6897

arrow-down$-0.0264 (-3.72%)

Prices updated at 12 Dec 2025, 09:20 EST

Prices minimum 15 mins delay

Prices in USD

CytoSorbents Corp is a immunotherapy company. The Company uses blood purification to modulate inflammation with the goal of preventing or treating multiple organ failure in life-threatening illnesses and cardiac surgery.

NASDAQ

-1.69%

NASDAQ

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Sector

Healthcare

Industry

Medical Devices

Chairman

Mr. Michael G. Bator

CEO

Dr. Phillip P. Chan, M.D.,PhD

Most recent earnings

31 Dec 2024

Fiscal year end

31 Dec 2024

Employees

149

Head office

305 College Road East

Princeton

United States

08540

+1 732 329-8885

avogel@cytosorbents.com

Company website

Key personnel

Owner name chevron-l-regular chevron-r-regular	Salary
Dr. Edward R. Jones, M.B.A.,M.D. Independent Director	0.07m
Mr. Peter J. Mariani Chief Financial Officer and Principal Accounting Officer	0.15m
Mr. Vincent J. Capponi, M.S. President and Chief Operating Officer	0.38m
Dr. Phillip P. Chan, M.D.,PhD Chief Executive Officer and Director	0.36m
Mr. Alan D. Sobel, C.P.A. Independent Director	0.09m
Mr. Michael G. Bator Chairman of the Board	0.12m
Dr. Efthymios Nikolaos Deliargyris, M.D. Chief Medical Officer	0.36m
Ms. Jiny Kim, M.B.A. Independent Director	0.07m

Top 5 shareholders

Owner name chevron-l-regular chevron-r-regular	No. of shares
Avenir Corporation	5,082,838
Skylands Capital, LLC	2,127,265
Vanguard Group Inc	2,124,759
Neuberger Berman Investment Advisers LLC	1,597,998
Neuberger Berman Group LLC	1,597,998

Director dealings

Date chevron-l-regular chevron-r-regular	Action
13 Dec 2024	-
12 Dec 2024	-
11 Dec 2024	-
04 Oct 2024	-
04 Oct 2024	-
04 Oct 2024	-
04 Oct 2024	-
14 Aug 2024	-
14 Aug 2024	-
14 Aug 2024	-
14 Aug 2024	-
14 Aug 2024	-
02 Apr 2024	-
02 Apr 2024	-
02 Apr 2024	-
02 Apr 2024	-
02 Apr 2024	-
02 Apr 2024	-
02 Apr 2024	-
02 Apr 2024	-

Please note that past performance is not a reliable indicator of future returns.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.